Standards & Regulation

We speak with experts from Amgen and Henry Ford Health about the development and approval of Uplizna for IgG4-related disease.

From bird flu to COVID-19 vaccines to alleged corruption in journals, we look into recent moves from US Health Secretary RFK Jr.

Our latest news roundup reports on a new blow for Harvard, how Pfizer and Astellas’ Xtandi improves cancer survival, and more.

We ask a company about lessons learned from the GMP certification process.

A report attempts to unravel the many challenges that face business leaders. We discuss those inherent in the pharmaceutical industry.

Audrey Greenberg’s latest insight on US-based manufacturing, Trump’s “Administration for A Healthy America”

The FDA says it wants to phase out mandatory animal testing requirements for drug approval. What comes next?

Our latest news roundup reports on changes at Novo Nordisk, AbbVie’s ADC accelerated approval, Regeneron’s new acquisition, and more.

Now that the 2025 Power List is live, we speak with the people working hard every day to make a difference.

Our latest roundup reports on Trump's “most favored nation” order, an EMA investigation into finasteride, and Novo Nordisk’s continued R&D for obesity